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Sonographic Evaluation for 
Endometrial Polyps
The Interrupted Mucosa Sign 
ndometrial polyps are benign focal overgrowths of endome-
trial tissue, often with variable amounts of vascularity and
stroma encased by epithelium. Although the etiology of
polyp development is unclear, endometrial polyps are quite com-
mon, identified in 13% to 50% of women with dysfunctional uter-
ine bleeding and 10% of asymptomatic patients undergoing routine
sonographic imaging.1 Standard treatment is hysteroscopic removal
to alleviate bleeding symptoms and exclude malignancy.2
Aya Kamaya, MD, Pauline Chang Yu, MD, Carla Ramas Lloyd, MD, Bertha H. Chen, MD, 
Terry S. Desser, MD, Katherine E. Maturen, MD
Received November 24, 2015, from the Depart-
ments of Radiology (A.K., T.S.D.) and Obstetrics
and Gynecology (B.H.C.), Stanford University
Medical Center, Stanford California USA;
Department of Obstetrics and Gynecology, Kaiser
Permanente, Santa Clara, CA (P.C.Y.); Virtual
Radiologic Professionals, LLC, Eden Prairie,
Minnesota USA (C.R.L.); and Department of
Radiology, University of Michigan, Ann Arbor,
Michigan USA (K.E.M.). Revision requested
January 5, 2016. Revised manuscript accepted for
publication February 6, 2016.
We thank Jeslyn A. Rumbold for editorial
assistance.
Address correspondence to Aya Kamaya,
MD, Department of Radiology, Stanford University




©2016 by the American Institute of Ultrasound in Medicine | J Ultrasound Med 2016; 35:2381–2387| 0278-4297 | www.aium.org
ORIGINAL RESEARCH
Objectives—To evaluate the interrupted mucosa sign for identification of endometrial
polyps, using pathologic confirmation as the reference standard, compared to other
accepted sonographic findings.
Methods—We reviewed 195 patients referred for pelvic sonographic evaluations for
suspected endometrial polyps in this retrospective Institutional Review Board–
approved study. Of these, 82 had tissue sampling of the endometrium and constituted
the final study group. Patient data, including age, menopausal status, last menstrual
period, and final pathologic diagnosis, were recorded. Sonograms were reviewed by 2
blinded board-certified radiologists for endometrial features, including thickness,
echogenicity, vascularity, presence of a mass, and the interrupted mucosa sign. Descrip-
tive statistics and multivariate logistic regression analysis were performed.
Results—The mean age of the patients was 44.99 (SD, 9.88) years, 79.1% of whom
were premenopausal. Pathologic diagnosis confirmed polyps in 58 (70.73%). A single
feeding vessel was visualized in 36 patients with polyps (62.07%), whereas the inter-
rupted mucosa sign was visualized in 34 (58.62%). The presence of a feeding vessel,
the interrupted mucosa sign, or both detected 48 (82.76%) of the polyps. In the multi-
variate analysis, only the interrupted mucosa sign was a statistically significant predictor
of pathologic diagnosis of a polyp (P = .035), with an odds ratio of 3.83 (95% confidence
interval, 1.10–13.29). Other sonographic findings were not independent predictors of a
polyp: mass (P = .35), single feeding vessel (P = .31), endometrial thickness (P = .88),
and endometrial echogenicity (P = .45). The sensitivity, specificity, and positive predic-
tive value of the interrupted mucosa sign were 59%, 75%, and 85%, respectively. 
Conclusions—The interrupted mucosa sign is a promising sonographic sign for iden-
tification of endometrial polyps, with greater predictive power than previously described
signs. It has the potential to improve the diagnostic performance of sonography, espe-
cially when used in combination with other described signs.
Key Words—dysfunctional uterine bleeding; endometrial polyp; feeding vessel; gyne-
cologic ultrasound; interrupted mucosa; pedicle artery sign 
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Typically, patients presenting with dysfunctional uter-
ine bleeding are first assessed by pelvic sonography.
Depending on sonographic findings, patients may be
referred for further evaluation with saline-infused sono-
hysterography or hysteroscopic removal. The most widely
accepted and commonly used sonographic features of a
polyp are an echogenic endometrial lesion with a single
feeding vessel.3–5 Although these findings are extremely
helpful, they are not always sonographically evident, and
visualization may depend on body habitus or timing of
imaging during the phase of menstrual cycle (Figure 1).6
In our clinical practice, we have observed an additional
sonographic finding: the interrupted mucosa sign, which
may help in the diagnosis of endometrial polyps. The inter-
rupted mucosa sign is identified when the highly echogenic
linear interface where opposing endometrial mucosal sur-
faces coapt can be followed to a point at which it is focally
interrupted (typically by an endometrial polyp). In our
experience, the focal interruption is usually best appreciated
on transvaginal transverse or longitudinal images of the
uterus during the first half of the menstrual cycle (Figure 2).
The interrupted mucosa sign may also be helpful during
the latter half of the menstrual cycle, when polyps may be
isoechoic to the endometrium and their borders indistinct
(Figures 3 and 4). The purpose of our study was to inves-
tigate the interrupted mucosa sign in the diagnosis of
endometrial polyps. 
Materials and Methods
We reviewed 195 patients referred for sonographic evalu-
ations of the female pelvis performed at out institution in
this retrospective Institutional Review Board–approved
study using the key word search term “polyp” in pelvic
sonographic reports. Informed consent was waived by the
Institutional Review Board. Of these patients, 82 had
pathologic confirmation of endometrial findings, and these
patients constituted our final study group. Patient data,
including age, menopausal status, last menstrual period,
and final pathologic diagnosis, were recorded. If the last
menstrual period date was not provided, the age of 50 years
or older was used as a threshold for categorization as
menopausal.
All sonographic examinations were performed by
American Registry for Diagnostic Medical Sonography–
certified sonographers under the supervision of a board-
certified radiologist. All examinations were performed on
either Acuson Sequoia 512 (Siemens Medical Solutions,
Mountain View, CA) or LOGIQ E9 (GE Healthcare,
Waukesha, WI) ultrasound machines. Transabdominal
images were typically obtained with a full bladder at 3–
6-MHz frequencies. Patients were then asked to empty
their bladder, and transvaginal images were obtained of the
uterus at 6–8-MHz frequencies with grayscale and color
Doppler imaging. Power and spectral Doppler evaluations
were used as deemed appropriate by the sonographer or
interpreting radiologist at the time of the examination, for
example, to provide greater sensitivity for detection of focal
vascularity or to characterize detected focal vascularity as
arterial or venous.
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Figure 1. Interrupted mucosa sign without a feeding vessel. An
echogenic polyp (blue arrow) is shown, which focally interrupts the
endometrial mucosa (yellow arrows). However, a feeding vessel was not
visualized on color Doppler imaging. 
Figure 2. Interrupted mucosa sign in a hypoechoic endometrial echo
complex. The mucosa is often best visualized during the first half of the
menstrual cycle, when the endometrium is hypoechoic in appearance.
In this example, the endometrial-mucosal interface (yellow arrows) is
clearly interrupted by a polyp (blue arrow).
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Sonograms were retrospectively reviewed in consen-
sus by 2 board-certified radiologists (A.K. and C.R.L.) for
the presence of the interrupted mucosa sign, sonographic
visibility of an endometrial mass, presence of a single
feeding vessel versus multiple vessels, and endometrial
appearance and thickness. The endometrial appearance
was assessed as hypoechoic, isoechoic, or echogenic
compared to the adjacent myometrium. Endometrial thick-
ness was measured at its maximum anteroposterior
thickness viewed in the sagittal plane with one caliper
placed in the anterior uterine wall at the margin of the basal
layer of the endometrium and the other caliper placed at
the same margin in the posterior uterine wall, excluding
fluid (if present) in the endometrial cavity.7 Radiologists
were blinded to the final pathologic diagnoses. Images,
including still images and cine clips (when available) were
reviewed on Syngo Kinetdx workstations (Siemens Med-
ical Solutions).
Descriptive statistical analyses were performed using
means, counts, and percentages, and comparisons were
made between the polyp and nonpolyp groups by a t test
for continuous variables, and a χ2 or Fisher exact test 
for categorical variables. Multivariate logistic regression for
prediction of the presence of polyps on pathologic exami-
nation was performed with automated forward selection
of variables, with P = .05 used as the inclusion criterion.
Age, menopausal status, and history of hormone
replacement therapy were included as a priori predictors.
Imaging findings, including the presence, size, echogenicity
(hypoechoic, isoechoic, or echogenic), and vascularity
(single or multiple feeding vessels) of a sonographic mass,
the interrupted mucosa sign, and interaction terms including
“menopause*interrupted sign” and “menopause*single feed-
ing vessel” were entered into automated forward selection
of variables. The diagnostic performance (sensitivity, speci-
ficity, positive predictive value, and negative predictive
value) of the interrupted mucosa sign was evaluated by
using pathologic confirmation as the reference standard.
All analyses were performed with SAS version 9.3 software
(SAS Institute Inc, Cary, NC).
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Figure 3. Interrupted mucosa sign. A subtle endometrial polyp (blue
arrow) is shown in an echogenic endometrial echo complex. The
echogenic mucosa (yellow arrows) can be followed to the level of the
polyp, which focally interrupts the mucosal line. Without careful evalua-
tion of the mucosa, the echogenic polyp may otherwise be difficult to
detect in a background of echogenic endometrium. 
Figure 4. Interrupted mucosa sign without an associated mass in a
pathologically proven 2-cm polyp. A, Grayscale transvaginal sonogram
showing that the mucosa (yellow arrows) is focally interrupted (blue
arrow), without a clear sonographically visible associated mass. B, Color
Doppler sonogram from the same patient showing a vessel in the
endometrium, which terminates as the point of the focal interruption (yel-
low arrow) of the endometrium. 
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Results
The study population consisted of 82 women, 79.1% of
whom were premenopausal. Patient demographics are
outlined in Table 1. The final pathologic diagnosis con-
firmed leiomyoma in 6 (7.32%) women, endometrial
hyperplasia in 2 (2.44%), polyps in 58 (70.73%), and no
abnormality in 16 (19.51%). Pathologic confirmation was
obtained by hysteroscopy in 72 patients, total hysterec-
tomy in 5, and endometrial biopsy in 5.
The sonographic findings are enumerated in Table 2.
In the univariate analysis, the detection frequency of a
sonographic mass and its size, echogenicity, and vascular-
ity did not differ significantly between the polyp and non-
polyp groups. The interrupted mucosa sign was much
more frequently present among polyps. A single feeding
vessel was identified in more patients with polyps than in
patients without polyps.
The presence of a feeding vessel, the interrupted
mucosa sign, or both detected 48 (82.76%) of the polyps;
22 (38.00%) had both a feeding vessel and interrupted
mucosa, and 26 (45.00%) had either a feeding vessel or
interrupted mucosa. In the evaluation of a mass versus
the interrupted mucosa sign, in patients with polyps, 30 of
58 (51.72%) had both a mass and the interrupted mucosa
sign; 7 (12.07%) did not have a mass or the interrupted
mucosa sign; 18 (31.03%) had a mass but no inter-
rupted mucosa sign; and 3 (5.17%) had the interrupted
mucosa sign but no mass. Of the patients without polyps, 6
of 24 (25.00%) had no mass or interrupted mucosa sign;
13 (54.17%) had a mass but no interrupted mucosa sign; 5
(20.83%) had both the interrupted mucosa sign and a mass;
and 0 had the interrupted mucosa sign but no mass.
Table 1. Clinical Characteristics of 82 Patients With Clinically Suspected Endometrial Polyps
Pathologic Diagnosis: Pathologic Diagnosis:
Characteristic Total + Polyp – Polyp P
Patients, n 82 58 24 NA
Mean age, y (SD) 44.99 (9.88) 44.65 (10.82) 45.79 (7.21) .63
Postmenopausal, n (%) 17 (20.99) 12 (20.83) 5 (21.05) .98
Hormone replacement therapy, n (%) 7 (8.64) 5 (8.33) 2 (8.77) >.99a
NA indicates not applicable.
aFisher exact test used for comparison because of low cell count.
Table 2. Univariate Analysis of Imaging Features of Endometrial Polyps Versus Other Pathologic Diagnoses, Including Leiomyoma, Hyper-
plasia, and No Pathologic Abnormality
Pathologic Diagnosis: Pathologic Diagnosis:
Characteristic Total + Polyp – Polyp P
Mass shown on sonography, n (%) 67 (81.71) 49 (84.48) 18 (75.00) .35a
Mean longest mass dimension, mm (SD) 11.64 (7.96) 11.14 (5.39) 13.00 (12.69) .40
Mean mass area, mm2 (SD)b 128.69 (178.36) 114.30 (119.10) 167.8 (285.00) .28
Echogenic compared to endometrium, n (%) 28 (41.79) 23 (46.94) 5 (27.78) .10
Isoechoic compared to endometrium, n (%) 28 (41.79) 18 (36.73) 10 (55.56) .36
Hypoechoic compared to endometrium, n (%) 11 (16.42) 8 (16.33) 3 (16.67) >.99a
Vascularity, n (%) 74 (90.24) 52 (89.66) 22 (92.67) >.99a
Single feeding vessel, n (%) 48 (58.54) 36 (62.07) 12 (50.00) .31
>1 feeding vessel, n (%) 12 (14.63) 6 (10.34) 6 (25.00) .10a
Interrupted mucosa sign, n (%) 40 (48.78) 34 (58.62) 6 (25.00) .006
Mean endometrial thickness, mm (SD) 10.75 (5.06) 10.81 (5.24) 10.62 (4.67) .88
Echogenic endometrium, n (%) 46 (56.10) 31 (37.80) 15 (62.50) .45
aFisher exact test used because of low cell counts.
bCalculated as an ellipse based on cross-sectional measurements in a sagittal view.
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The sensitivity, specificity, positive predictive value,
and negative predictive value of the interrupted mucosa sign
were 59%, 75%, 85%, and 43%, respectively (Figures 5–7).
For a single feeding vessel, these values were 62%, 50%,
75%, and 50%, and for the presence of a mass, the values
were 84%, 25%, 73%, and 40%.
In the multivariate logistic regression, only the inter-
rupted mucosa sign was retained as a statistically significant
predictor of pathologic diagnosis of polyp. There was no
statistically significant interaction effect (P > .05)
between menopause status and the interrupted mucosa
sign or menopause and the presence of a single feeding
vessel as imaging predictors of the polyp outcome.
Parameter estimates and results of the logistic regression
analysis are given in Table 3.
Discussion 
The sonographic diagnosis of an endometrial polyp remains
clinically challenging. Indeed, most imaging features on
which radiologists rely were either not predictive or simply
may not have reached the threshold of significance for
pathologic diagnosis of polyps in our study, including
echogenicity, vascularity, size of a mass, and even sono-
graphic detection of a mass. However, we describe a new
imaging feature: the interrupted mucosa sign, which was
the only statistically significant predictor of pathologic
diagnosis of a polyp in the multivariate logistic regression
analysis.
We believe that this sonographic finding is related to
the underlying pathologic nature of endometrial polyps
itself. These polyps are focal overgrowths of the
endometrium; thus, their origin is within the endometrium.
An endometrial polyp would therefore focally interrupt the
normal mucosal contour of the uterine cavity. In contrast,
J Ultrasound Med 2016; 35:2381–2387 2385
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Figure 5. False-positive interrupted mucosa sign. An echogenic mass
(blue arrow) is shown, which focally interrupts the mucosal line (yellow
arrows). However, on blind endometrial biopsy, pathologic examination
only showed a proliferative endometrium, and no polyp was identified. 
Figure 6. False-positive interrupted mucosa sign. A, An echogenic
mass (blue arrows) is shown, which focally interrupts the mucosal line
(yellow arrows). B, T2 weighted magnetic resonance image of the uterus
showing that the mass (blue arrow) is a submucosal fibroid. 
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fibroids arise from the myometrium and characteristically
have a covering layer of endometrium. A submucosal
fibroid, therefore, would not typically interrupt the
endometrial mucosa. As with other sonographic findings,
the interrupted mucosa sign is more likely to be visualized
during the first half of the menstrual cycle, when the
endometrium is thinner and relatively hypoechoic.
If an endometrial polyp is suspected, patients are often
further evaluated with saline-infused sonohysterography
when the pelvic sonogram shows an abnormality.
Although saline-infused sonohysterography can be help-
ful in further delineating the endometrium, it has several
potential drawbacks: first, the technique may cause more
discomfort and higher cost to patients; second, conditions
such as cervical stenosis may preclude such an evaluation8;
and third, some studies have raised the concern that saline-
infused sonohysterography can lead to intraperitoneal
spillage of malignant cells with unsuspected endometrial
malignancy.9 Therefore, if a polyp can be confidently diag-
nosed on conventional sonography, those patients may be
directly treated with hysteroscopic removal and avoid
saline-infused sonohysterography. We think that the addi-
tional sonographic finding of an interrupted mucosa can
help in triaging patients directly toward hysteroscopic
removal of an endometrial polyp and avoiding confirma-
tory but nontherapeutic saline-infused sonohysterography.
Several previous studies have compared the sensitivity
of routine pelvic sonography to saline-infused sonohys-
terography for identification of endometrial polyps.10–13
However, many of these studies only included patients
with findings on pelvic sonography, which were then fur-
ther characterized by saline-infused sonohysterography,
leading to a selection bias and apparently improved detec-
tion rates for saline-infused sonohysterography. In fact, the
standard pelvic sonographic examination is extremely
important in this chain of evaluation, yet there are very few
studies in the literature that have looked solely at the
features of endometrial polyps on conventional pelvic
sonography. The most commonly cited sonographic feature
is the pedicle artery sign, described by Timmerman et al3 in
2003, in which a single feeding vessel is identified on color
Doppler sonography. In a slightly older publication by
Baldwin et al,14 a hyperechoic line along the periphery of
the endometrial cavity was found to be a good predictor 
of fibroids, polyps, hyperplasia, and localized neoplasms.
However, in that study, this sign was not used to distin-
guish among these entities.
There were several limitations to our study. First, it
was a retrospective evaluation, and the initial patient list
was selected on the basis of a clinical or sonographic sus-
picion of an endometrial polyp, which led to an artificially
high prevalence of endometrial polyps that is not reflective
of the general population in clinical practice and limited
evaluation of the true sensitivity and specificity of the sign.
Therefore, these estimates must be interpreted with cau-
tion. In addition, clinically silent endometrial polyps may
not constitute a proportional subset of the study group;
however, because we required pathologic confirmation of
Kamaya et al—Sonographic Evaluation for Endometrial Polyps
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Figure 7. False-negative interrupted mucosa sign. An isoechoic mass
(blue arrows) is shown abutting and distorting but not interrupting the
mucosal line (yellow arrows) in this patient, who was confirmed to have
a polyp on pathologic examination. 
Table 3. Results and Parameter Estimates From Multivariate Logistic Regression Analysis of Clinical and Imaging Features Predictive of
Pathologic Diagnosis of a Polyp
Parameter Estimate SE P OR (95% CI)
Intercept 2.15 2.12 .311 NA
Age –0.05 0.05 .335 0.95 (0.87–1.05)
Postmenopausal 0.97 1.15 .399 2.63 (0.28–25.03)
Hormone replacement therapy 0.76 1.27 .541 2.17 (0.18–26.11)
Interrupted mucosa sign 1.34 0.64 .035 3.83 (1.10–13.29)
CI indicates confidence interval; NA, not applicable; and OR, odds ratio.
3511jum2373-2412 copy  10/25/16  1:42 PM  Page 2386
endometrial findings, this selection bias was unavoidable.
The second limitation of our study was that the patient
cohort was relatively small; because we maintained a
rigorous standard requiring definitive tissue diagnosis of
endometrial contents, this approach limited the number
of patients in our study cohort. A third limitation was
that there were no cancers identified in our study group.
However, the expected incidence of cancer in our study
population is relatively low (0.5%–3%),15–17 and other
studies have found few if any endometrial cancers in their
populations of patients with abnormal vaginal bleeding.3,12
Nonetheless, we do not have the needed data to analyze
whether the interrupted mucosa sign is helpful in differen-
tiating endometrial polyps from cancers. A fourth limita-
tion of our study was that, although all patients had
pathologic correlation, 5 of the 82 patients only had blind
endometrial biopsy, and it is possible that on blind endo -
metrial biopsy, an endometrial polyp identified by sonog-
raphy could potentially be missed (Figure 5). Another
limitation was that distinguishing focal interruption from
displacement from a submucosal fibroid may in some cases
be difficult, potentially leading to false-positive results (Fig-
ure 6). Finally, we do not know how often the mucosal line
is simply not visualized in some individuals, in whom the
usefulness of this finding would be limited.
In conclusion, the interrupted mucosa sign is a prom-
ising sonographic feature for identification of endometrial
polyps and could contribute to patient care by directing
patients to prompt hysteroscopy, thereby potentially
avoiding intermediate invasive confirmatory tests such as
saline-infused sonohysterography. 
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